Annals of Clinical Endocrinology and Metabolism

AcademicKeys
Publons
Google Scholar
Google Scholar

Contact Information

Heighten Science Publications Corporation

+4043820291
hcem@heighpubs.us
info@heighpubs.us
2504 Stillwater CT, Flower Mound
Texas - 75022, USA

Send us a Mail

We've received your message.
Thank you!
Articles Journals Editors Reviewers
Heighpubs » hcem » articles

Volume 1 Issue 1

  • article icon
    Research Article
    Published: 08/29/2017 | Pages: 1(1): 015-019

    Parathyroid Functions in Thalassemia Major Patients

    Ayfer Gözü Pirinççioğlu*, Deniz Gökalp and Murat Söker

    Background: Hypoparathyroidism is well known to occur in thalassemia major patients, but it is thought to be uncommon and its incidence is considered to be decreasing with improvements in chelation therapy. The
    objective of this study was to assess the prevalence of parathyroid dysfunction in the fi rst decade of life of the patients with thalassemia major.

    PDF   HTML

  • article icon
    Research Article
    Published: 08/04/2017 | Pages: 1(1): 007-014

    Effect on Vitamin D status of Breastfeeding Infants after Vitamin D3 Supplementation during Breastfeeding Lactation: A double-blind randomized controlled trial

    Sathit Niramitmahapanya*, Surasak Kaoiean, Varaporn Sangtawesin, Anusorn Patpanaprapan, Narisa K Bordeerat and Chaicharn Deerochanawong

    Background: Vitamin D defi ciency in pregnancy increases several risks of breastfed mothers. To prevent these adverse events, vitamin D supplementation during pregnancy and lactation is recommended, but suggested dose ranges vary.
    Objective: To determine whether vitamin D3 1,800 IU/d supplementation in lactating mothers improves the vitamin D status of their breastfed infants.

    PDF   HTML

  • article icon
    Case Report
    Published: 03/15/2017 | Pages: 1(1): 01-05

    Recurrent Cardiac Events Driven by Prothrombotic Burden in a Patient Undergoing Lipoprotein Apheresis for High Lp(a) Levels

    Gabriele Cioni*, Rossella Marcucci, Rosanna Abbate and Giovanna D’Alessandri

    Introduction: Lipoprotein (a) [Lp(a)] is a marker for cardiovascular disease, involved in pathogenesis and progression of atherosclerosis. In selected high-risk patients, lipoprotein-apheresis could optimize secondary prevention and improve prognosis.

    Aim: We presented the case of a 49-year-old man with high lipoprotein (a) levels and recurrent cardiac adverse events, despite maximal pharmacological therapy.Introduction: Lipoprotein (a) [Lp(a)] is a marker for cardiovascular disease, involved in pathogenesis and

    progression of atherosclerosis. In selected high-risk patients, lipoprotein-apheresis could optimize secondary
    prevention and improve prognosis

    PDF   HTML